Jim Simons Vanda Pharmaceuticals Inc. Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 4,011,522 shares of VNDA stock, worth $18.8 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,011,522
Previous 4,114,125
2.49%
Holding current value
$18.8 Million
Previous $23.2 Million
19.06%
% of portfolio
0.03%
Previous 0.04%
Shares
24 transactions
Others Institutions Holding VNDA
# of Institutions
161Shares Held
45.2MCall Options Held
165KPut Options Held
33.6K-
Black Rock Inc. New York, NY8.14MShares$38.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$17 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$11 Million0.94% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$10.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.9MShares$8.89 Million0.03% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $265M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...